<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01822327</url>
  </required_header>
  <id_info>
    <org_study_id>R01DA009378</org_study_id>
    <nct_id>NCT01822327</nct_id>
  </id_info>
  <brief_title>Treating Cocaine Abuse: A Behavioral Approach</brief_title>
  <official_title>Treating Cocaine Abuse: A Behavioral Approach</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Vermont</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Vermont</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study is designed to advance our development of a treatment for cocaine dependence. The
      investigators hypothesize that clients with high-risk characteristics will benefit from
      enhanced levels of treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Treatment development for cocaine dependence often proceeds without effort to adapt treatment
      parameters to patient characteristics. Such a one-size-fits-all approach is problematic
      because of the heterogeneity of the clinical population. Additionally, the approach is often
      subject to opposing biases either towards constraining costs or maximizing efficacy. This
      project includes two sequential clinical trails examining variations of the CRA + Vouchers
      treatment for cocaine dependence that are designed to explore matching treatment parameters
      to patient baseline characteristics known to moderate treatment response among
      cocaine-dependent outpatients. In Trial 1, all patients were randomly assigned to receive 24
      weeks of CRA therapy but randomly assigned to one of three voucher-based incentive
      conditions: (a) 6 weeks of vouchers contingent on abstinence and incentive monetary value at
      usual level; (b) 6 weeks of vouchers contingent on abstinence but incentive value set at
      usual level for low-severity patients (intranasal cocaine users or married patients) and at
      twice the usual value for high severity patients (i.e., unmarried cocaine smokers/injectors),
      or to (c) a control condition where incentives were provided independent of recent cocaine
      use. In Trial 2, all patients receive 12 weeks of abstinence-contingent incentives, but
      randomly assigned to also receive (a) 24 weeks of CRA therapy or (b) 4 weeks of CRA therapy.
      The overarching goal of the two trials is to strike a balance between the aforementioned
      biases towards constraining costs or maximizing efficacy and thereby facilitate cost
      containment without compromising efficacy, especially among more severe patients.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Active, not recruiting</last_known_status>
  <start_date>December 2007</start_date>
  <completion_date type="Anticipated">March 2014</completion_date>
  <primary_completion_date type="Anticipated">March 2014</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Biochemically-Verified Cocaine Use</measure>
    <time_frame>2 years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Addiction Severity Inventory Scores</measure>
    <time_frame>2 years</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">124</enrollment>
  <condition>Cocaine Dependence</condition>
  <arm_group>
    <arm_group_label>Contingent Vouchers Unmatched</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRA therapy plus Voucher incentives contingent on cocaine abstinence with monetary values set at usual monetary values across all patients.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Contingent Vouchers, Matched</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CRA therapy plus Vouchers contingent on cocaine abstinence, with more severe patients receiving twice the usual voucher monetary values.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Non-Contingent Vouchers control</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>CRA therapy plus Vouchers earned independent of drug use</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>CRA plus Vouchers contingent on drug abstinence with values the same across all patients</description>
    <arm_group_label>Contingent Vouchers Unmatched</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>CRA plus Vouchers contingent on cocaine abstinence with more severe patients receiving greater value vouchers</description>
    <arm_group_label>Contingent Vouchers, Matched</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Contingency Management</intervention_name>
    <description>CRA plus Vouchers earned independent of cocaine use</description>
    <arm_group_label>Non-Contingent Vouchers control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18 years and older

          -  Meets DSM IV criteria for cocaine dependence

        Exclusion Criteria:

          -  Psychosis

          -  Pregnancy

          -  Leaving immediate geographic area sooner than 6 months

          -  An organic psychiatric disorder

          -  Medical illness such that participation is not feasible (e.g., on dialysis).

          -  Subjects in acute alcohol withdrawal

          -  Uncontrolled seizure disorder

          -  Significant depression or suicidal ideation (pending psychological evaluation)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Stephen T Higgins, Ph.D</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Vermont</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Substance Abuse Treatment Center, University of Vermont; UHC</name>
      <address>
        <city>Burlington</city>
        <state>Vermont</state>
        <zip>05401</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>García-Rodríguez O, Secades-Villa R, Higgins ST, Fernández-Hermida JR, Carballo JL. Financing a voucher program for cocaine abusers through community donations in Spain. J Appl Behav Anal. 2008 Winter;41(4):623-8.</citation>
    <PMID>19192866</PMID>
  </reference>
  <reference>
    <citation>Higgins, S.T., Heil, S.H., Rogers, R.E., &amp; Chivers, L. (2008). Cocaine. In S.T. Higgins, K. Silverman, &amp; S.H. Heil (Eds.), Contingency management in substance abuse treatment (pp. 19-410. New York, NY: The Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Higgins, S.T., Sigmon, S.C., Heil, S.H. (2008). Drug abuse and dependence. In D.H. Barlow (Ed.), Clinical handbook of psychological disorders (4th ed.). (pp. 547-577). New York: Guilford Publications, Inc.</citation>
  </reference>
  <reference>
    <citation>Higgins, S.T. &amp; Silverman, K., (2008). Contingency Management. In M. Galanter and H.D. Kleber (Eds.) Textbook of substance abuse treatment (4th ed.). (pp. 387-399). The American Psychiatric Press..</citation>
  </reference>
  <reference>
    <citation>Higgins, S.T. &amp; Silverman, K. (2008). Introduction. In S.T. Higgins, K. Silverman, &amp; S.H. Heil (Eds.), Contingency management in substance abuse treatment (pp. 1-15). New York, NY: The Guilford Press.</citation>
  </reference>
  <reference>
    <citation>Rogers RE, Higgins ST, Silverman K, Thomas CS, Badger GJ, Bigelow G, Stitzer M. Abstinence-contingent reinforcement and engagement in non-drug-related activities among illicit drug abusers. Psychol Addict Behav. 2008 Dec;22(4):544-50. doi: 10.1037/0893-164X.22.4.544.</citation>
    <PMID>19071979</PMID>
  </reference>
  <reference>
    <citation>Silverman K, Roll JM, Higgins ST. Introduction to the special issue on the behavior analysis and treatment of drug addiction. J Appl Behav Anal. 2008 Winter;41(4):471-80.</citation>
    <PMID>19192853</PMID>
  </reference>
  <reference>
    <citation>Garcia-Rodriguez O, Secades-Villa R, Higgins ST, Fernandez-Hermida JR, Carballo JL, Errasti Perez JM, Al-halabi Diaz S. Effects of voucher-based intervention on abstinence and retention in an outpatient treatment for cocaine addiction: a randomized controlled trial. Exp Clin Psychopharmacol. 2009 Jun;17(3):131-8. doi: 10.1037/a0015963.</citation>
    <PMID>19586227</PMID>
  </reference>
  <reference>
    <citation>Higgins ST. Comments on contingency management and conditional cash transfers. Health Econ. 2010 Oct;19(10):1255-8. doi: 10.1002/hec.1543.</citation>
    <PMID>19670269</PMID>
  </reference>
  <reference>
    <citation>Higgins, S. T., Heil, S. H., &amp; Sigmon, S. C. (2010). Voucher-based contingency management in the treatment of substance use disorders. In G. J. Madden (Ed.), APA Handbook of Behavior Analysis. Washington, DC: American Psychological Association.</citation>
  </reference>
  <results_reference>
    <citation>Higgins, S.T. and Rogers, R.E. (2009). Contingency management and community reinforcement approach. In Peter M. Miller (Ed.). Evidence-based addiction treatment (pp. 249-267). Burlington: Academic Press, Elsevier Inc.</citation>
  </results_reference>
  <verification_date>March 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 26, 2013</study_first_submitted>
  <study_first_submitted_qc>March 27, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 2, 2013</study_first_posted>
  <last_update_submitted>March 27, 2013</last_update_submitted>
  <last_update_submitted_qc>March 27, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 2, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Vermont</investigator_affiliation>
    <investigator_full_name>Stephen T. Higgins</investigator_full_name>
    <investigator_title>Professor of Psychiatry and Psychology</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine-Related Disorders</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cocaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

